Researchers design graphene quantum dots for cancer treatment
Researchers at China's Hunan University, Chinese Academy of Sciences and the University of Washington in the U.S have developed a metal-free nanozyme based on graphene quantum dots (GQDs) for highly efficient tumor chemodynamic therapy (CDT).
GQDs have potential as a cost-effective means of addressing the toxicity concerns associated with metal-based nanozymes in tumor CDT. However, the limited catalytic activity of GQDs has posed significant challenges for their clinical application, particularly under challenging catalytic conditions. "The obtained GQDs, which are made from red blood cell membranes, are highly effective in treating tumors with few side effects," said Liu Hongji, a member of the research team. "One of the advantages is that they are metal-free. In addition, they function as excellent peroxidase-like biocatalysts."